Skip to Main Content
Text size: SmallMediumLargeExtra-Large

Selected Publications

  1. Alevizos I, Alexander S, Turner RJ, et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren’s syndrome. Arthritis Rheum 2011; 63:535-544.
  2. Alevizos I, Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010; 6:391-398.
  3. Korman BD, Alba MI, Le JM, et al. Variant form of STAT4 is associated with primary Sjögren’s syndrome. Genes Immun 2008; 9:267-270.
  4. Nikolov NP, Illei GG. Pathogenesis of Sjögren’s syndrome. Curr Opin Rheumatol 2009; 21:465-470.
  5. Michael D, Soi S, Cabera-Perez J, et al. Microarray analysis of sexually dimorphic gene expression in human minor salivary glands. Oral Dis 2011.
  6. Roescher N, Kingman A, Shirota Y, et al. Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjögren’s syndrome. Ann Rheum Dis 2011; 70:235-236.
  7. Illei GG, Shirota Y, Yarboro CH, et al. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 2010; 62:542-552.
  8. Roescher N, Vosters JL, Yin H, et al. Effect of soluble ICAM-1 on a Sjögren’s syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One 2011; 6:e19962.
  9. Zheng C, Nikolov NP, Alevizos I, et al. Transient detection of E1-containing adenovirus in saliva after the delivery of a first-generation adenoviral vector to human parotid gland. J Gene Med 2010; 12:3-10.
  10. Roescher N, Tak PP, Illei GG. Cytokines in Sjögren's syndrome: potential therapeutic targets. Ann Rheum Dis 2010; 69:945-948.
  11. Cobb BL, Fei Y, Jonsson R, et al. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren’s syndrome. Ann Rheum Dis 2010; 69:1731-1732.
  12. Baum BJ, Zheng C, Cotrim AP, et al. Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. Handb Exp Pharmacol 2009:403-418.
  13. Austin HA, 3rd, Illei GG, Braun MJ, et al. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 2009; 20:901-911.
  14. Ryu OH, Atkinson JC, Hoehn GT, et al. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology (Oxford) 2006; 45:1077-1086.

 

 

Share This Page

GooglePlusExternal link – please review our disclaimer

LinkedInExternal link – please review our disclaimer

Print

This page last updated: May 28, 2014